Pulse Entdecken nav.journalClub Debatten Trends Forschende Zeitschriften

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Start Entdecken nav.journalClub Trends

⌘+K

Treatments for renal cell carcinoma: NICE Pilot Treatment Pathways Appraisal. | Synapse

January 22, 20261 citations

View Full Paper

Treatments for renal cell carcinoma: NICE Pilot Treatment Pathways Appraisal.

DLDawn LeeUniversity of Exeter MMMadhusubramanian MuthukumarUniversity of Exeter ALAlan LovellUniversity of Exeter

Key Points

The aim is to assess and appraise treatment pathways for renal cell carcinoma under NICE guidelines.
Conducted a systematic review of existing treatment pathways.
Utilized data from the National Institute for Health and Care Research.
Engaged stakeholders in the evaluation process.
Identified gaps in current treatment pathways.
Proposed recommendations for improving renal cancer management.
Enhanced understanding of patient care in renal cell carcinoma.

Abstract

This award was funded by the National Institute for Health and Care Research (NIHR) Evidence Synthesis programme (NIHR award ref: NIHR136008) and is published in full in Health Technology Assessment; Vol. 30, No. 1. See the NIHR Funding and Awards website for further award information.

KI fragen

Like

Bookmark

Share

View Full Paper

KI fragen

Like

Bookmark

Share

View Full Paper

Cite This Study

Lee et al. (Thu,) studied this question.

synapsesocial.com/papers/6971bd26642b1836717e1e5e https://doi.org/https://doi.org/10.3310/gjdl0327